Electrical stimulation of human muscle studied using 31P-nuclear magnetic resonance spectroscopy. 1986

D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega

This study used phosphorous nuclear magnetic resonance (31P-NMR) spectroscopy to examine the metabolic demand resulting from electrical muscle stimulation (EMS) applied to human skeletal muscle. For each of six subjects, the forearm flexor muscle group was monitored with 31P-NMR during both maximum voluntary and 6-s EMS-induced contractions. A simple protocol using a tourniquet was added in one subject to assess the role of blood flow in this model. Eight hertz (nontetanic) EMS showed less (p less than 0.025) depletion of phosphocreatine (36%) than did tetanic 70-Hz EMS (60%), voluntary isometric (66%), and voluntary isokinetic (68%). The results of the tourniquet studies suggested that the nontetanic EMS allowed relatively increased muscle blood flow and oxygen supply during contraction. Tetanic EMS provided a similar metabolic demand to that of conventional resistive exercise, as measured by 31P-NMR spectroscopy.

UI MeSH Term Description Entries
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D010759 Phosphorus Isotopes Stable phosphorus atoms that have the same atomic number as the element phosphorus, but differ in atomic weight. P-31 is a stable phosphorus isotope. Isotopes, Phosphorus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
June 1976, The Journal of physiology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
December 1990, European journal of vascular surgery,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
May 1991, Digestive diseases and sciences,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
June 1990, Seminars in perinatology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
January 1992, Archives of oral biology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
October 1992, Canadian journal of physiology and pharmacology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
May 1991, Canadian journal of physiology and pharmacology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
November 1993, The Journal of rheumatology,
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
October 2000, Rheumatology (Oxford, England),
D W Shenton, and R B Heppenstall, and B Chance, and S G Glasgow, and M D Schnall, and A A Sapega
July 1987, Annals of neurology,
Copied contents to your clipboard!